CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
Top Cited Papers
- 13 February 2025
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 392 (7) , 677-685
Abstract
We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel (cilta-cel) in the phase 3 CARTITUDE-4 trial. Monoclonal T cells from both patients had detectable CAR transgene expression and integration. The clinicogenomic features of these CAR transgenic T-cell lymphoproliferative neoplasms suggest that multiple potential intrinsic or extrinsic factors (or both) contributed to their pathogenesis, such as transduction of preexisting TET2-mutated T cells, followed by acquisition of further oncogenic genomic variants. Other potential contributors include germline genomic variation, viral infections, and previous treatment for myeloma. In the absence of direct evidence, the contribution of insertional mutagenesis to the development of T-cell lymphoma is currently unclear. (Funded by Johnson & Johnson and Legend Biotech USA; CARTITUDE-4 ClinicalTrials.gov number, NCT04181827.).Keywords
This publication has 23 references indexed in Scilit:
- Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyNew England Journal of Medicine, 2024
- Secondary Cancers after Chimeric Antigen Receptor T-Cell TherapyNew England Journal of Medicine, 2024
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaNew England Journal of Medicine, 2023
- TET2 guards against unchecked BATF3-induced CAR T cell expansionNature, 2023
- VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2Nature Methods, 2022
- The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid NeoplasmsLeukemia, 2022
- Second primary malignancies in multiple myeloma: A reviewBlood Reviews, 2020
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- An integrated encyclopedia of DNA elements in the human genomeNature, 2012
- CD4/CD8 double-negative early-stage mycosis fungoides associated with primary cutaneous follicular center lymphomaJournal of the American Academy of Dermatology, 2011